Mortality of New York children with sickle cell disease identified through newborn screening

Genetics in Medicine

Volumn 17, Issue 6, 2015, Pages 452-459

  Wang, Ying ^a,b   Liu, Gang ^a   Caggana, Michele ^a,c   Kennedy, Joseph ^d   Zimmerman, Regina ^d   Oyeku, Suzette O ^e   Werner, Ellen M ^f   Grant, Althea M ^g   Green, Nancy S ^h   Grosse, Scott D ^g  

^a UNIVERSITY AT ALBANY   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^c WADSWORTH CENTER   (United States)

^d NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^e CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^h New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN S;

ARTICLE; BIRTH INJURY; CAUSE OF DEATH; CHILD; CHILDHOOD MORTALITY; COLITIS; CONGENITAL MALFORMATION; DEATH CERTIFICATE; FEMALE; GASTROENTERITIS; HEMOGLOBIN SC DISEASE; HISPANIC; HUMAN; IMMATURITY; INTUSSUSCEPTION; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; NEWBORN SCREENING; PREMATURITY; RISK ASSESSMENT; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; UNITED STATES; ANEMIA, SICKLE CELL; FOLLOW UP; GENETICS; HEALTH SURVEY; INFANT; MORTALITY; NEW YORK; NEWBORN; PHENOTYPE; PRESCHOOL CHILD; RISK FACTOR;

ANEMIA, SICKLE CELL; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN, SICKLE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MORTALITY; NEONATAL SCREENING; NEW YORK; PHENOTYPE; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 84930324280     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2014.123     Document Type: Article

References (40)

1. Brousseau DC, Panepinto JA, Nimmer M, Hoffmann RG. The number of people with sickle-cell disease in the United States: national and state estimates. Am J Hematol 2010;85:77-78.
2. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med 2010;38(suppl 4):S512-S521.
3. Siddiqui S, Schunk K, Batista M, et al. Awareness of sickle cell among people of reproductive age: Dominicans and African Americans in northern Manhattan. J Urban Health 2012;89:53-58.
4. Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest 2007;117:850-858.
5. Wang Y, Kennedy J, Caggana M, et al. Sickle cell disease incidence among newborns in New York State by maternal race/ethnicity and nativity. Genet Med 2013;15:222-228.
6. Darbari DS, Panepinto JA. What is the evidence that hydroxyurea improves health-related quality of life in patients with sickle cell disease? Hematology Am Soc Hematol Educ Program 2012;2012:290-291.
7. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics 1989;84:500-508.
8. Scott RB. Health care priority and sickle cell anemia. JAMA 1970; 214:731-734.
9. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-1644.
10. Gill FM, Sleeper LA, Weiner SJ, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood 1995;86:776-783.
11. Davis H, Schoendorf KC, Gergen PJ, Moore RM Jr. National trends in the mortality of children with sickle cell disease, 1968 through 1992. Am J Public Health 1997;87:1317-1322.
12. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood 2004;103:4023-4027.
13. Yanni E, Grosse SD, Yang Q, Olney RS. Trends in pediatric sickle cell diseaserelated mortality in the United States, 1983-2002. J Pediatr 2009;154:541-545.
14. Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood 2010;115:3447-3452.
15. Hamideh D, Alvarez O. Sickle cell disease related mortality in the United States (1999-2009). Pediatr Blood Cancer 2013;60:1482-1486.
16. Lanzkron S, Carroll CP, Haywood C Jr. Mortality rates and age at death from sickle cell disease: U.S., 1979-2005. Public Health Rep 2013;128:110-116.
17. Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B. Newborn screening for sickle cell disease: effect on mortality. Pediatrics 1988;81:749-755.
18. Frempong T, Pearson HA. Newborn screening coupled with comprehensive follow-up reduced early mortality of sickle cell disease in Connecticut. Conn Med 2007;71:9-12.
19. Benson JM, Therrell BL Jr. History and current status of newborn screening for hemoglobinopathies. Semin Perinatol 2010;34:134-144.
20. American Academy of Pediatrics. Section on Hematology/Oncology Committee on Genetics. Health supervision for children with sickle cell disease. Pediatrics 2002;109:526-535.
21. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986;314:1593-1599.
22. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;332:1317-1322.
23. Steinberg MH, McCarthy WF, Castro O, et al.; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up. Am J Hematol 2010;85:403-408.
24. Wang WC, Ware RE, Miller ST, et al.; BABY HUG investigators. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet 2011;377:1663-1672.
25. Adamkiewicz TV, Silk BJ, Howgate J, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics 2008;121:562-569.
26. Kemper AR, Boyle CA, Aceves J, et al. Long-term follow-up after diagnosis resulting from newborn screening: statement of the US Secretary of Health and Human Services' Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children. Genet Med 2008;10:259-261.
27. Hinton CF, Mai CT, Nabukera SK, et al. Developing a public health-tracking system for follow-up of newborn screening metabolic conditions: a four-state pilot project structure and initial findings. Genet Med 2014;16:484-490.
28. Wang Y, Caggana M, Sango-Jordan M, Sun M, Druschel CM. Long-term follow-up of children with confirmed newborn screening disorders using record linkage. Genet Med 2011;13:881-886.
29. Wang Y, Sango-Jordan M, Caggana M. Acute care utilization for inherited metabolic diseases among children identified through newborn screening in New York state. Genet Med 2014;16:665-670.
30. Hemoglobinopathy Monitoring. Centers for Disease Control and Prevention. http://www.cdc.gov/ncbddd/hemoglobinopathies/index.html. Accessed 1 May, 2014.
31. Newborn Screening Program, New York State Department of Health. Annual Reports. Online publications. http://www.wadsworth.org/newborn/annualrept/annsum.htm. Accessed 1 May, 2014.
32. Centers for Disease Control and Prevention (CDC). Mortality among children with sickle cell disease identified by newborn screening during 1990-1994 - California, Illinois, and New York. MMWR Morb Mortal Wkly Rep 1998;47:169-172.
33. Urquia ML, Glazier RH, Blondel B, et al.; ROAM collaboration. International migration and adverse birth outcomes: role of ethnicity, region of origin and destination. J Epidemiol Community Health 2010;64: 243-251.
34. Vang ZM, Elo IT. Exploring the health consequences of majority-minority neighborhoods: minority diversity and birthweight among native-born and foreign-born blacks. Soc Sci Med 2013;97:56-65.
35. Whiteman V, Salinas A, Weldeselasse HE, et al. Impact of sickle cell disease and thalassemias in infants on birth outcomes. Eur J Obstet Gynecol Reprod Biol 2013;170:324-328.
36. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. Deaths: final data for 2006. Natl Vital Stat Rep 2009;57:1-134.
37. Grosse SD, Sarafoglou K. Does newborn screening have 100% sensitivity to detect salt-wasting CAH? A word of caution. JAMA Pediatrics, in press.
38. Nembhard WN, Salemi JL, Ethen MK, Fixler DE, Dimaggio A, Canfield MA. Racial/Ethnic disparities in risk of early childhood mortality among children with congenital heart defects. Pediatrics 2011;127:e1128-e1138.
39. Marengo LK, Hoyt AT, Canfield MA. The utility of the National Death Index as a supplemental data source in ascertaining 5-year mortality among Texas heterotaxy cases. J Registry Manag 2014;41:4-6.
40. Payne AB, Link-Gelles R, Azonobi I, et al.; Active Bacterial Core Surveillance Team. Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009. Pediatr Infect Dis J 2013;32:1308-1312.